Skip to content

(1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide

C37H39F3N8O4 — CID 159038998

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC(1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide
SMILESCC(=O)c1nn2c3c(cc(-c4cnc(C)cn4)cc13)CCCCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3
InChIInChI=1S/C37H39F3N8O4/c1-20-10-11-28(37(38,39)40)44-34(20)45-35(52)27-14-36-15-29(36)48(27)31(51)18-47-33-23(8-6-4-5-7-9-30(50)43-19-36)12-24(26-17-41-21(2)16-42-26)13-25(33)32(46-47)22(3)49/h10-13,16-17,27,29H,4-9,14-15,18-19H2,1-3H3,(H,43,50)(H,44,45,52)/t27-,29+,36-/m0/s1
InChIKeyRTCHJDASFRDYCD-ZULCAZRWSA-N
MW716.77 g/mol
LogP5.35
Rot. Bonds4

About (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide

(1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide (PubChem CID 159038998) has the molecular formula C37H39F3N8O4 and a molecular weight of 716.77 g/mol. Its IUPAC name is (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide.

Molecular Properties

Compound Name(1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide
PubChem CID159038998
Molecular FormulaC37H39F3N8O4
Molecular Weight716.77 g/mol
Exact Mass716.30
IUPAC Name(1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide
SMILESCC(=O)c1nn2c3c(cc(-c4cnc(C)cn4)cc13)CCCCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3
InChIInChI=1S/C37H39F3N8O4/c1-20-10-11-28(37(38,39)40)44-34(20)45-35(52)27-14-36-15-29(36)48(27)31(51)18-47-33-23(8-6-4-5-7-9-30(50)43-19-36)12-24(26-17-41-21(2)16-42-26)13-25(33)32(46-47)22(3)49/h10-13,16-17,27,29H,4-9,14-15,18-19H2,1-3H3,(H,43,50)(H,44,45,52)/t27-,29+,36-/m0/s1
InChIKeyRTCHJDASFRDYCD-ZULCAZRWSA-N
XLogP5.35
TPSA152.07 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds4
Heavy Atoms52
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500716.77
LogP ≤ 55.35
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide?
The IUPAC name of (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide (CID 159038998) is (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide.
What is the SMILES notation for (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide?
The canonical SMILES for (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide is CC(=O)c1nn2c3c(cc(-c4cnc(C)cn4)cc13)CCCCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3.
What is the InChIKey of (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide?
The InChIKey is RTCHJDASFRDYCD-ZULCAZRWSA-N. The full InChI is InChI=1S/C37H39F3N8O4/c1-20-10-11-28(37(38,39)40)44-34(20)45-35(52)27-14-36-15-29(36)48(27)31(51)18-47-33-23(8-6-4-5-7-9-30(50)43-19-36)12-24(26-17-41-21(2)16-42-26)13-25(33)32(46-47)22(3)49/h10-13,16-17,27,29H,4-9,14-15,18-19H2,1-3H3,(H,43,50)(H,44,45,52)/t27-,29+,36-/m0/s1.
What are the key properties of (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide?
(1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide has a molecular weight of 716.77 g/mol, XLogP of 5.35, 4 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,22R,25S)-16-acetyl-13-(5-methylpyrazin-2-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide is sourced from PubChem (CID 159038998), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.